Metabolon Inc., of Research Triangle Park, N.C., appointed Tim Germann vice president of sales, Bruce McCreedy vice president for strategic development and Dan Stevens director of marketing.

New River Pharmaceuticals Inc., of Radford, Va., appointed James Shaffer vice president, sales and marketing.

NexMed Inc., of East Windsor, N.J., appointed David Tierney to its board.

Oramed Pharmaceuticals Inc., of Jerusalem, added Derek LeRoith to its scientific board.

Resverlogix Corp., of Calgary, Alberta, named Daniel Rader and Jacques Genest to its clinical review committee.

Rigel Pharmaceuticals Inc., of South San Francisco, appointed Bradford Goodwin to its board.